James Robinson

James A. Robinson is President, Chief Executive Officer & Director at Urovant Sciences Ltd. since 2020.
He is President, Chief Executive Officer & Director at A2 Biotherapeutics, Inc. starting in 2024.
He serves as Director at Kenneth C.
Griffin Museum of Science & Industry, Chicago Horticultural Society, and Petauri Health LLC.
He is Independent Director at UroGen Pharma Ltd. and Eledon Pharmaceuticals, Inc. since 2023.
He is a Member of The Commercial Club of Chicago and Chicagonext (Bioscience Council).
Formerly, Mr. Robinson was Chief Executive Officer at Qlarity Imaging LLC.
He was President, Chief Executive Officer & Director at Urovant Sciences, Inc. from 2020 to 2023.
He was Director at Beacon Therapeutics (USA), Inc. from 2021 to 2022.
He was Director at World Business Chicago.
He was Independent Director at Neos Therapeutics, Inc. from 2019 to 2021.
He was Treasurer & Director at Pharmaceutical Research & Manufacturers of America in 2018.
He was Director & Founding Member at Innovation Development Institute, Inc. He was President & Chief Operating Officer at Alkermes, Inc. from 2018 to 2019.
He was Vice President-Hepatitis Sales & Managed Care at Schering-Plough Corp.
from 1992 to 2002.
He was President at Astellas Pharma US, Inc. from 2013 to 2016.
He was President at Astellas US LLC from 2016 to 2018.
He was President & Chief Operating Officer at Alkermes Plc from 2018 to 2019.
He was President & Chief Operating Officer at Paragon Biosciences LLC from 2019 to 2020.
Education includes an undergraduate degree from DePaul University conferred in 1992.